Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways

Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome

(2009) Changye Zou et al.   ANNALS OF SURGERY

[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1

(2009) Victoria S. Warbey et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Expression and significance of EGFR in malignant peripheral nerve sheath tumor

(2009) Daniel Keizman et al.   JOURNAL OF NEURO-ONCOLOGY

A 10-Year Review of Benign and Malignant Peripheral Nerve Sheath Tumors in a Single Center: Clinical and Radiographic Features Can Help to Differentiate Benign from Malignant Lesions

(2009) Dominic Furniss et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients

(2008) F. Perrone et al.   ANNALS OF ONCOLOGY

It Takes a (Dysfunctional) Village to Raise a Tumor

(2008) Karlyne M. Reilly et al.   CELL

Differential expression of angiogenic factors in peripheral nerve sheath tumors

(2008) Junji Wasa et al.   CLINICAL & EXPERIMENTAL METASTASIS

High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization

(2008) K. K. Mantripragada et al.   CLINICAL CANCER RESEARCH

Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations

(2008) J LOPICCOLO et al.   DRUG RESISTANCE UPDATES

Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1

(2008) Lianne C. Krab   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Phase I Trial of the Novel Mammalian Target of Rapamycin Inhibitor Deforolimus (AP23573; MK-8669) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients With Advanced Malignancies

(2008) Monica M. Mita et al.   JOURNAL OF CLINICAL ONCOLOGY

Germline and somaticNF1mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours

(2008) Irene Bottillo et al.   JOURNAL OF PATHOLOGY

Induction of Apoptosis in Neurofibromatosis Type 1 Malignant Peripheral Nerve Sheath Tumor Cell Lines by a Combination of Novel Farnesyl Transferase Inhibitors and Lovastatin

(2008) J. W. Wojtkowiak et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Malignant peripheral nerve sheath tumor: Molecular pathogenesis and current management considerations

(2008) Stephen R. Grobmyer et al.   JOURNAL OF SURGICAL ONCOLOGY

Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells

(2008) G. Ambrosini et al.   MOLECULAR CANCER THERAPEUTICS

Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors

(2008) G. Johansson et al.   MOLECULAR CANCER THERAPEUTICS

EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy

(2008) Nikola Holtkamp et al.   NEURO-ONCOLOGY

Malignant Peripheral Nerve Sheath Tumors

(2008) Gaurav Gupta et al.   NEUROSURGERY CLINICS OF NORTH AMERICA

Epidermal Growth Factor Receptor Expression and Mutational Analysis in Synovial Sarcomas and Malignant Peripheral Nerve Sheath Tumors

(2008) H. Tawbi et al.   ONCOLOGIST

Neurofibromin as a regulator of melanocyte development and differentiation

(2007) G. Diwakar et al.   JOURNAL OF CELL SCIENCE